Your browser doesn't support javascript.
loading
Could hepatitis B vaccine act as an adjuvant to lower risk and relapses of cancer?
Altinoz, Meric A; Ozpinar, Aysel; Ozpinar, Alp; Hacker, Emily; Elmaci, Ilhan.
Affiliation
  • Altinoz MA; Department of Medical Biochemistry, Acibadem University, Istanbul, Turkey.
  • Ozpinar A; Department of Medical Biochemistry, Acibadem University, Istanbul, Turkey.
  • Ozpinar A; School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Hacker E; School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Elmaci I; Department of Neurosurgery, Acibadem University, Istanbul, Turkey.
Clin Exp Pharmacol Physiol ; 46(8): 694-704, 2019 08.
Article in En | MEDLINE | ID: mdl-31002181
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adjuvants, Immunologic / Hepatitis B Vaccines / Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Clin Exp Pharmacol Physiol Year: 2019 Type: Article Affiliation country: Turkey
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adjuvants, Immunologic / Hepatitis B Vaccines / Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Clin Exp Pharmacol Physiol Year: 2019 Type: Article Affiliation country: Turkey